SCG101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCG101, covering 2025-02-18 to 2025-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma [Phase 1, Phase 2]